Active	Status	Sponsor type	Region	Phase	Filter
9 Active 0 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

9 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Taddeo, Matt
EQUATE, NCT03763318: A Study to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHD	Completed	1b/2	30	US	EQ001, Bmab600, Itolizumab, EQ001 Placebo	Equillium, Biocon Limited	Acute-graft-versus-host Disease, aGVHD, GVHD, GVHD, Acute	11/22	11/22
NCT05238142: In-Home Study with MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults with Insulin-requiring Type 2 Diabetes	Active, not recruiting	N/A	575	US	MiniMed™ 780G Insulin Pump system	Medtronic Diabetes	Type 2 Diabetes Treated with Insulin	01/25	02/25
Sutton, David
DREAM-T2D, NCT04854512 / 2020-000763-23: Investigational Study of Delayed Release Metformin	Suspended	3	675	Europe, Canada, US, RoW	Metformin DR, ANJ900, MetDR, Metformin IR, Metformin DR Placebo, Metformin IR placebo	Anji Pharma	Diabetes Mellitus, Type 2	12/23	06/24
PREVAIL, NCT05202509 / 2021-005092-39: Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease	Active, not recruiting	3	9541	Europe, Canada, Japan, US, RoW	Obicetrapib, Placebo	NewAmsterdam Pharma, Monash University	Atherosclerotic Cardiovascular Disease	11/26	11/26
SURMOUNT-MMO, NCT05556512: A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity	Active, not recruiting	3	15374	Europe, Canada, Japan, US, RoW	Tirzepatide, LY3298176, Placebo	Eli Lilly and Company	Obesity, Overweight	10/27	10/27
NCT05325294: Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®	Completed	N/A	244	US	MiniMed 780G System	Medtronic Diabetes, Eli Lilly and Company	Type 1 Diabetes	01/24	01/24
NCT05238142: In-Home Study with MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults with Insulin-requiring Type 2 Diabetes	Active, not recruiting	N/A	575	US	MiniMed™ 780G Insulin Pump system	Medtronic Diabetes	Type 2 Diabetes Treated with Insulin	01/25	02/25
Edson, Meghan
NCT05325294: Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®	Completed	N/A	244	US	MiniMed 780G System	Medtronic Diabetes, Eli Lilly and Company	Type 1 Diabetes	01/24	01/24
NCT05238142: In-Home Study with MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults with Insulin-requiring Type 2 Diabetes	Active, not recruiting	N/A	575	US	MiniMed™ 780G Insulin Pump system	Medtronic Diabetes	Type 2 Diabetes Treated with Insulin	01/25	02/25